About Octane Biotech
Octane Biotech is a Healthcare company based in Lucknow (India) founded in 2004 by Sanjiv Agarwal. It produces pharmaceutical items like tablets, capsules, and injections for worldwide distribution. It operates on a B2B and D2C model. The company has 80 employees. Its Indian entity Octane Biotech Private Limited reported revenue of ₹17.08 Cr. Octane Biotech offers products and services including Tablets, Capsules, Injections, Syrups, and Infusions. Its focus areas include Pharmaceuticals, Drug Manufacturing and Formulations. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Octane Biotech Pvt. Ltd. is a pharmaceutical company based in Lucknow, India, focused on manufacturing high-quality products such as tablets, capsules, injections, syrups, and ointments at economical rates. It aims to serve global markets by partnering with customers and distributors, emphasizing timely delivery and inventory control to reduce healthcare costs. The company commits to ethical practices and innovation in drug production for societal welfare.
- Headquarters Lucknow, India
- Employees 80
- Founders Sanjiv Agarwal
- SectorsHealthcare
- Email••••••••
- Website octanebiotech.net
- Social Facebook
- Legal Name Octane Biotech Private Limited
- Date of Incorporation 25 May, 2004
- Jurisdiction Lucknow, Uttar Pradesh, India
- Annual Revenue₹17.08 Cr
FY 2025 · +1% YoY
- Net Profit₹29.2 Lakh
FY 2025 · 2% margin
- EBITDA₹84.3 Lakh
FY 2025 · 5% margin
- Employee Count80
Associated legal entities of Octane Biotech
Octane Biotech operates through Octane Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Octane Biotech Private Limited CIN U24232UP2004PTC028667 | Active | 25 May 2004 | Lucknow, Uttar Pradesh | ₹17.1 Cr | 80 | 3 | View details |
Products & Services of Octane Biotech
Octane Biotech offers a comprehensive portfolio of products and services, including Tablets, Capsules, Injections, Syrups, and Infusions.
Medicinal tablets for treating various health conditions effectively
Capsules containing active ingredients for targeted health treatments
Injectable solutions for immediate medical interventions and care
Liquid syrups for oral administration in managing illnesses
Infusion solutions for intravenous delivery in hospital settings
Topical ointments for skin treatments and external applications
Board of directors of Octane Biotech Private Limited (Octane Biotech)
Octane Biotech Private Limited is the primary company behind Octane Biotech. The board of Octane Biotech Private Limited currently have 3 directors; the longest-serving is Sanjiv Agarwal, appointed in 2004. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Agarwal DIN 00970950 | Director | 25 May 2004 | 22 yrs 4 mo | Octane Biotech Private Limited |
| Deepa Agarwal DIN 03336772 | Director | 03 May 2011 | 15 yrs 5 mo | Octane Biotech Private Limited |
| Pulkit Agarwal DIN 10696678 | Director | 15 Jul 2024 | 2 yrs 3 mo | Octane Biotech Private Limited |
People of Octane Biotech
1 people are tracked at Octane Biotech (1 in leadership); the tracked headcount is 80.
| Name | Role | Group |
|---|---|---|
| Founder, MD | Leadership |
Complete people profiles for Octane Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Octane Biotech
Figures of Octane Biotech Private Limited, the primary company behind Octane Biotech, for FY 2025. Revenue was ₹17.08 Cr (+1% year on year). Net profit was ₹29.2 Lakh (2% margin). EBITDA was ₹84.3 Lakh (5% margin). Revenue has grown at a compounded annual rate of +9% over three years and +2% over five years.
- ₹17.08 CrRevenue · FY 2025 · +1% YoY
- ₹29.2 LakhNet profit · 2% margin
- ₹84.3 LakhEBITDA · 5% margin
- ₹2.9 LakhPaid-up capital
- 80Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Octane Biotech Private Limited are on its company page.
Detailed financial statements for Octane Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Octane Biotech
Octane Biotech has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Octane Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Octane Biotech (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Octane Biotech
Complete news archive for Octane Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Octane Biotech
Octane Biotech was founded in 2004.
Octane Biotech is headquartered in Lucknow, India. It is registered at Lucknow, Uttar Pradesh, India.
Octane Biotech has 80 employees.
The primary company behind Octane Biotech, Octane Biotech Private Limited, reported revenue of ₹17.08 Cr for FY 2025, up 1% year on year.
Octane Biotech Pvt. Ltd. is a pharmaceutical company based in Lucknow, India, focused on manufacturing high-quality products such as tablets, capsules, injections, syrups, and ointments at economical rates. It aims to serve global markets by partnering with customers and distributors, emphasizing timely delivery and inventory control to reduce healthcare costs. The company commits to ethical practices and innovation in drug production for societal welfare.
Octane Biotech's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Octane Biotech offers Tablets, Capsules, Injections, Syrups, and 2 more products and services.
Octane Biotech operates through Octane Biotech Private Limited.
The legal entities of Octane Biotech currently have 3 directors, including Deepa Agarwal, Sanjiv Agarwal, Pulkit Agarwal.